1,610
Views
0
CrossRef citations to date
0
Altmetric
Editorial

A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitus

, &
Pages 95-98 | Received 04 Jan 2022, Accepted 16 Feb 2022, Published online: 25 Feb 2022

References

  • Sinclair AJ, Abdelhafiz AH, and Rodríguez-Mañas L. Frailty and sarcopenia-newly emerging and high impact complications of diabetes. J Diabetes Complications. 2017;31:1465–1473.
  • Hanlon P, Fauré I, Corcoran N, et al. Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis. Lancet Healthy Longev. 2020;1:e106–e116 .
  • Sinclair AJ, Abdelhafiz A, Dunning T, et al. An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J Frailty Aging. 2018;7:10–20.
  • LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of diabetes in older adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1520–1574.
  • Abdelhafiz AH, Emmerton D, and Sinclair AJ. Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus. Geriatr Gerontol Int. 2021;21:614–622.
  • Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62A:731–737.
  • Castrejon-Perez RC, Aguilar-Salinas CA, Gutierrez-Robledo LM, et al. Frailty, diabetes, and the convergence of chronic disease in an age-related condition: a population-based nationwide cross-sectional analysis of the Mexican nutrition and health survey. Aging Clin Exp Res. 2018;30:935–941.
  • Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.
  • Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45:353‐60.
  • Kojima G. Frailty defined by FRAIL scale as a predictor of mortality: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018;19:480–483.
  • Rockwood K, Theou O. Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr J. 2020;23:254–259.
  • Pulok MH, Theou O, van der Valk AM, et al. The role of illness acuity on the association between frailty and mortality in emergency department patients referred to internal medicine. Age Ageing. 2020;49:1071–1079.
  • Pette D, Peuker H, Staron RS. The impact of biochemical methods for single fibre analysis. Acta Physiol Scand. 1999;166:261–277.
  • Sonjak V, Jacob K, Morais JA, et al. Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women. J Physiol. 2019;597:5009–5023.
  • Watanabe D, Yoshida T, Watanabe Y, Kyoto-Kameoka Study Group. et al. A U-Shaped relationship between the prevalence of frailty and body mass index in community-dwelling Japanese older adults: the Kyoto-Kameoka study. J Clin Med. 2020;9:1367.
  • Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010;23:148–156.
  • Kalyani RR, Varadhan R, Weiss CO, et al. Frailty status and altered glucose-insulin dynamics. J Gerontol A Biol Sci Med Sci. 2012;67:1300–1306.
  • Goulet ED, Hassaine A, Dionne IJ, et al. Frailty in the elderly is associated with insulin resistance of glucose metabolism in the postabsorptive state only in the presence of increased abdominal fat. Exp Gerontol. 2009;44:740–744.
  • Reza M, Taylor C, Towse K, et al. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract. 2002;55:201–207.
  • Bradley MC, Chillarige Y, and Lee H, et al. Severe hypoglycemia risk with long-acting insulin analogs vs neutral protamine hagedorn insulin. JAMA Intern Med. 2021;181:598–607.
  • Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes. a systematic review and meta-analysis. Ann Intern Med. 2016;164:740–751.
  • Crowley MJ, Diamantidis CJ, McDuffie JR, et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Ann Intern Med. 2017;166:191–200.
  • Abdelhafiz AH, Sinclair AJ. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy. J Diabetes Complications. 2020;34:107639.
  • Chang YC, Chuang LM, Lin JW, et al. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study. Diabet Med. 2015;32:1460–1469.
  • Stout MB, Justice JN, Nicklas BJ, et al. Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty. Physiology (Bethesda). 2017;32:9–19.
  • Abdelhafiz AH, Rodríguez-Ma˜nas L, and Morley JE, et al. Hypoglycemia in older people-a less well recognized risk factor for frailty. Aging Dis. 2015;10:156–167.
  • Zaslavsky O, Walker RL, Crane PK, et al. Glucose levels and risk of frailty. J Gerontol A Biol Sci Med Sci. 2016;71:1223–1229.
  • Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40:140–146.
  • Godino JG, Appel LJ, Gross AL, et al. Diabetes, hyperglycemia, and the burden of functional disability among older adults in a community-based study. J Diabetes. 2017;9:76–84.
  • Yau CK, Eng C, Cenzer IS, et al. Glycosylated hemoglobin and functional decline in community dwelling nursing home-eligible elderly adults with diabetes mellitus. J Am Geriatr Soc. 2012;60:1215–1221.
  • Ahlqvist E, Storm P, Karajamaki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.